Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Leo Pharma begins phase IIa study of LEO-138559 for moderate to severe atopic dermatitis

July 27, 2021

PolarityTE submits IND for SkinTE in chronic cutaneous ulcers

July 27, 2021

Gilead studies GS-5718 in phase Ib for cutaneous lupus erythematosus

July 23, 2021

Dosing commences in phase II study of STP-705 for keloid scar prevention

July 15, 2021

Escient reports phase I data on EP-547 for pruritus associated with cholestasis and uremia

July 15, 2021

HT-003 reduces expression of inflammatory cytokines in acne therapeutic model

July 15, 2021

FDA clears IND for Kintor's GT-20029 for androgenetic alopecia and acne

July 14, 2021

Tyrosine-protein kinase ITK/TSK inhibitors discovered at Pfizer

July 14, 2021

EscharEx debridement agent demonstrates efficiency, safety in chronic wound study

July 13, 2021

FDA clears initiation of phase II trial of pyrilutamide in androgenetic alopecia

July 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...